Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Schrodinger

Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies. Read more

235 Followers on Owler
235 Followers on Owler
235 Followers on Owler
235 Followers on Owler

Schrodinger

Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies. Read more

Ramy Farid's photo - President & CEO of Schrodinger

President & CEO

Ramy Farid

CEO Approval Rating

88/100

Founded:

1990

Status:

PublicIndependent CompanyNASDAQSDGR

SIC Code:

2836 NAICS listing »

Website:

Annual Revenue
Employees
Sector
Internet Software
Enterprise Software
Headquarters

SCHRODINGER TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

The top 10 competitors in Schrodinger's competitive set are Atomwise, Exscientia Ltd., Numerate, Chemical Computing Group, MolySym, Wavefunction, Rescale, Cyrus Biotechnology Inc., Certara, Cyclica and Pharmacelera. Together they have raised over 1.7B between their estimated 1.4K employees. Schrodinger has 450 employees and is ranked 2nd among it's top 10 competitors. The top 10 competitors average 156.

Atomwise is one of Schrodinger's top competitors. Atomwise was founded in 2012, and its headquarters is in San Francisco, California. Atomwise competes in the Artificial Intelligence (AI) field. Atomwise has 395 fewer employees than Schrodinger.

Exscientia Ltd. is Schrodinger's #2 rival. Exscientia Ltd. was founded in 2012 in Dundee, Scotland. Exscientia Ltd. competes in the Health Care Technology industry. Exscientia Ltd. generates $104M less revenue than Schrodinger.

Numerate is a top competitor of Schrodinger. Numerate is a Private company that was founded in San Francisco, California in 2007. Numerate operates in the Biotechnology industry. Numerate has 400 fewer employees vs. Schrodinger.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is MolySym a competitor of Schrodinger?

I don't know

Trending News for Schrodinger and Schrodinger's Competitors

May 12, 2021

Markets Insider

Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in ... See more »

Schrodinger Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$114M

Schrodinger's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 44.7M. Over the last four quarters, Schrodinger's revenue has grown by 39.1%. Specifically, in Q1 2021's revenue was $32.1M; in Q4 2020, it was $33M; in Q3 2020, it was $25.8M; in Q2 2020, Schrodinger's revenue was $23.1M.

Schrodinger Acquisitions

No recent acquisitions found related to Schrodinger

Schrodinger Funding History

Since Schrodinger was founded in 1990, it has participated in 5 rounds of funding. In total Schrodinger has raised $394.6M. Schrodinger's last funding round was on Feb 2020 for a total of $232.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Feb 2020
$232.6M
-
Equity
Nov 2018
$110M
Equity
Jun 2015
$22M
-
Equity
Dec 2012
$20M
-
Equity
Apr 2010
$10M
-

Total Funding: $394.6M

Since Schrodinger was founded in 1990, it has participated in 5 rounds of funding. In total Schrodinger has raised $394.6M. Schrodinger's last funding round was on Feb 2020 for a total of $232.6M

Schrodinger Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Bright Angel Therapeutics focuses on the development of novel drugs for the treatment of drug-resistant and fungal infections.
-
Dec 02, 2019
Seed
-
Nimbus Therapeutics is a biotechnology company that develops and commercializes drugs for the treatment of cancer and immune-inflammatory diseases.
$65M
Jun 04, 2018
Equity
Apr 01, 2016
Morphic Therapeutic develops and commercializes oral integrin drugs for the treatment of immunological, fibrotic and neoplastic diseases.
$51.5M
Jun 29, 2016
Series A
Jun 26, 2019
Nimbus Therapeutics is a biotechnology company that develops and commercializes drugs for the treatment of cancer and immune-inflammatory diseases.
$3.5M
Apr 14, 2010
Equity
Apr 01, 2016

Schrodinger News

April 26, 2021Commercial Observer

Pharmaceutical Software Developer Schrdinger Inks 109K Lease at 1540 Broadway

Pharmaceutical software developer Schrödinger signed a lease for 108,849 square feet at Edge Funds' 1... See more »
April 26, 2021Real Estate Weekly

Pharma giant leases 109,000 s/f at 1540 Broadway

Pharmaceutical software developer Schrödinger Inc. has signed a lease for 109,000 s/f at 1540 Broadwa... See more »
April 16, 2021MarketScreener

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

(marketscreener.com) Schrödinger, Inc. , whose physics-based software platform is transforming the wa... See more »
April 12, 2021MarketScreener

NVIDIA Partners with Schrdinger to Further Accelerate Drug Discovery Worldwide

(marketscreener.com) SANTA CLARA, Calif., April 12, 2021 -- GTC -- NVIDIA today announced a strategic... See more »
April 9, 2021MarketScreener

Technology-Enabled Drug Discovery

(marketscreener.com) Schrödinger , whose physics-based software platform is transforming the way ther... See more »
March 30, 2021MarketScreener

to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting

(marketscreener.com) Schrödinger , whose physics-based software platform is transforming the way ther... See more »
March 26, 2021Seeking Alpha

Schrdinger (SDGR) Investor Presentation - Slideshow

See more »

Schrodinger Press Releases

April 12, 2021Business Wire

Schrdinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting

NEW YORK--(BUSINESS WIRE)---- $SDGR #AACR21--Schrödinger presented new preclinical data from its CDC7... See more »
February 25, 2021centralcharts

Schrdinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives

Schrödinger, Inc. (Nasdaq: SDGR) today announced it has expanded its collaboration with Google Cloud ... See more »
November 12, 2020Business Wire

Schrdinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is... See more »
November 5, 2020Business Wire

Schrdinger to Host Third Quarter 2020 Financial Results Conference Call and Webcast

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based software platform is trans... See more »
June 16, 2020Business Wire

Schrdinger to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger announced that members of the management team will participate... See more »
May 28, 2020centralcharts

Schrdinger to Present at the Jefferies 2020 Virtual Healthcare Conference

Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, ... See more »
April 8, 2019Business Wire

Schrödinger Receives Clinical-Stage Milestone Payment from Sanofi Collaboration

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced receipt of a milestone payment from Sanofi (EU... See more »

Schrodinger Videos

November 12, 2020Schrodinger Youtube Channel

"Schrdinger Release - New Features 2020-4" on YOUTUBE

See more »
September 17, 2020Schrodinger Youtube Channel

"Schrdinger - Our Story" on YOUTUBE

See more »
August 13, 2020Schrodinger Youtube Channel

"Schrdinger Release - New Features 2020-3" on YOUTUBE

See more »
July 11, 2020Schrodinger Youtube Channel

"Maestro & PyMOL on The Looking Glass" on YOUTUBE

See more »
May 20, 2020Schrodinger Youtube Channel

"Schrdinger Release - New Features 2020-2" on YOUTUBE

See more »
March 26, 2020Schrodinger Youtube Channel

"Science at Schrödinger (Grades 6-12)" on YOUTUBE

See more »
February 27, 2020Schrodinger Youtube Channel

"Schrödinger Release - New Features 2020-1" on YOUTUBE

See more »

Social Media

Schrodinger Headquarters

120 West 45th Street 17th Floor

New York, New York10036

1-212-295-5800

Driving Directions »

Trending Companies

Schrodinger Summary

ABOUT

Overview

Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies. Schrodinger was founded in 1990. Schrodinger's headquarters is located in New York, New York, ...

CEO

Schrodinger's President & CEO, Ramy Farid, currently has an approval rating of 88%. Schrodinger's primary competitors are Atomwise, Exscientia Ltd. & Numerate.

Website

schrodinger.com

Frequently Asked Questions about Schrodinger

  1. When was Schrodinger founded?

    Schrodinger was founded in 1990

  2. Who is Schrodinger's CEO?

    Schrodinger's CEO is Ramy Farid

  3. How much revenue does Schrodinger generate?

    Schrodinger generates $114M in revenue

  4. How much funding does Schrodinger have?

    Schrodinger has historically raised $394.6M in funding

  5. Where is Schrodinger's headquarters?

    Schrodinger's headquarters is in New York New York, USA

  1. How many employees does Schrodinger have?

    Schrodinger has 450 employees

  2. What sector does Schrodinger operate in?

    Schrodinger is in Internet Software, Enterprise Software

  3. Who are Schrodinger's competitors?

    Schrodinger's top competitors are Atomwise, Exscientia Ltd., Numerate

  4. Who has Schrodinger invested in?

    Schrodinger's has invested in companies such as Bright Angel Therapeutics, Nimbus Therapeutics, Morphic Therapeutic
Stay up-to-date with the latest news on Schrodinger

© 2021 Owler, Inc.